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Two-color, rolling-circle amplification on antibody microarrays for sensitive, multiplexed serum-protein measurements The ability to conveniently and rapidly profile a diverse set of proteins has valuable applications. In a step toward further enabling such a  capability, we developed the use of rolling-circle amplification (RCA) to measure the relative levels of proteins from two serum samples,  labeled with biotin and digoxigenin, respectively, that have been captured on antibody microarrays. Two-color RCA produced fluorescence  up to 30-fold higher than direct-labeling and indirect-detection methods using antibody microarrays prepared on both polyacrylamide- based hydrogels and nitrocellulose. Replicate RCA measurements of multiple proteins from sets of 24 serum samples were highly repro- ducible and accurate. In addition, RCA enabled reproducible measurements of distinct expression profiles from lower-abundance proteins  that were not measurable using the other detection methods. Two-color RCA on antibody microarrays should allow the convenient acqui- sition of expression profiles from a great diversity of proteins for a variety of applications.
Abstract
The ability to conveniently and rapidly profile a diverse set of proteins has valuable applications. In
a step toward further enabling such a capability, we developed the use of rolling-circle amplification
(RCA) to measure the relative levels of proteins from two serum samples, labeled with biotin and
digoxigenin, respectively, that have been captured on antibody microarrays. Two-color RCA
produced fluorescence up to 30-fold higher than direct-labeling and indirect-detection methods
using antibody microarrays prepared on both polyacrylamide-based hydrogels and nitrocellulose.
Replicate RCA measurements of multiple proteins from sets of 24 serum samples were highly
reproducible and accurate. In addition, RCA enabled reproducible measurements of distinct
expression profiles from lower-abundance proteins that were not measurable using the other
detection methods. Two-color RCA on antibody microarrays should allow the convenient
acquisition of expression profiles from a great diversity of proteins for a variety of applications.
Background
Recent reports have shown the feasibility and value of anti-
body microarrays for the highly multiplexed analysis of pro-
teins in biological samples [1-11]. The ability to rapidly and
reproducibly measure multiple proteins in biological samples
is clearly valuable both for the better understanding of biol-
ogy and for the development of improved clinical diagnostics.
Despite the great interest in chip-based protein assays, the
routine application of antibody microarrays to biological
research has yet to be broadly established. Significant effort is
now underway to develop robust platforms that can be used
for a variety of research areas and that produce consistent,
reliable results. We present a step toward the development of
such a platform.
Two major types of antibody microarray detection systems
have emerged: sandwich assays, which employ a matched
pair of antibodies specific for every protein target; and label-
based detection, which uses covalently attached tags, such as
biotin or the fluorophores Cy3 and Cy5, on the target proteins
to enable detection after proteins bind to the array. Sandwich
assays can provide both high sensitivity and high specificity
and have been effectively demonstrated in the parallel meas-
urements of low-abundance cytokines in culture superna-
tants and body fluids [3,10].
Label-based detection is an attractive complementary alter-
native to the sandwich assay. An advantage of label-based
detection is ease in assay development. As only one antibody
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per target is required, as opposed to a pair of antibodies for a
sandwich assay, it is easier to obtain and test antibodies to a
broad diversity of proteins, and the expansion of an antibody
array to accommodate new antibodies is straightforward. In
addition, multicolor fluorescence detection is made possible
when the targeted proteins are labeled. As different samples
may be labeled with different tags, a reference sample may be
co-incubated with a test sample to provide internal normali-
zation to account for concentration differences between
spots. The two-color strategy is broadly used in DNA micro-
array experiments and has been used in antibody microarray
experiments to detect multiple proteins in serum [1,7], cell
culture [5,8,12] and tissue lysates [11].
While label-based detection is accurate and reproducible in
the analysis of higher-abundance proteins, the detection sen-
sitivity has not been sufficient to reliably detect lower-abun-
dance proteins in biological samples using current
methodology. The lack of signal amplification, as in methods
such as enzyme-linked immunosorbent assay (ELISA), is a
major cause of the lack of sensitivity [13]. A method to amplify
the signal from labeled proteins would enhance the sensitivity
of the direct-labeling format and expand its usefulness for a
broad range of biological applications.
Rolling-circle amplification (RCA) has been used for sensitiv-
ity enhancement in DNA quantitation [14], DNA mutation
detection [15,16], and array-based sandwich immunoassays
[3,17]. RCA is well suited for planar, multiplexed assays as the
covalently attached amplified product cannot diffuse away.
Also, the isothermal amplification process used in RCA pre-
serves the integrity of the antibody-antigen complexes. To
take advantage of these features for our antibody microarray
assay, we investigated whether RCA could be adapted to pro-
vide sensitivity enhancement in a label-based detection, two-
color antibody microarray assay. Such an approach would
combine the advantages of the direct-labeling format, such as
flexibility, expandability and multicolor detection, with the
high sensitivity afforded by RCA.
We therefore developed the use of RCA to detect labeled pro-
teins from two different samples captured on antibody micro-
arrays. Two-color RCA was applied to the measurement of
multiple proteins from two different sets of serum samples
using microarrays prepared on both polyacrylamide-based
hydrogels and nitrocellulose. Two other label-based methods
- direct labeling (the attachment of fluorescent dyes directly
to analyze proteins) and indirect detection (the attachment of
biotin and digoxigenin tags to analyze proteins followed by
detection using dye-labeled secondary antibodies) were also
used to analyze the serum samples, and the accuracy, repro-
ducibility and sensitivity of the methods were compared.
These experiments allowed a full evaluation of the perform-
ance of two-color RCA for serum-protein profiling.
Results
Development of two-color RCA
We developed and evaluated a method (termed two-color
RCA) to amplify fluorescence signals by RCA from two popu-
lations of proteins captured on antibody microarrays (Figure
1). Two pools of proteins, representing a test sample and a ref-
erence sample, are covalently labeled with biotin and digoxi-
genin, respectively, and incubated together on an antibody
microarray. After the labeled proteins bind to immobilized
antibodies according to their specificities, antibodies target-
ing the biotin tag and the digoxigenin tag are incubated on the
microarray. The anti-biotin and anti-digoxigenin antibodies
each are covalently conjugated to 'primer 1' and 'primer 4.2',
respectively. Two types of circular DNA, one with a portion
complementary to primer 1 and another with a portion com-
plementary to primer 4.2, hybridize to their respective prim-
ers, and DNA polymerase extends the primers by traveling
repeatedly around the circular DNA template. Oligonucle-
otide 'decorators', complementary to the repeating extended
strand from primer 1 or primer 4.2 and labeled with Cy3 or
Cy5, respectively, are hybridized to the extended fragments,
resulting in signal amplification in two colors.
We observed no cross-reactivity between the two circle types
and the opposing primers nor between the two decorator
types and the opposing extended strands under our incuba-
tion conditions (data not shown). We also examined the
cross-reactivity between the RCA antibodies and the capture
antibodies or the biotin and digoxigenin labels. Serum sam-
ples labeled with biotin were incubated on antibody microar-
rays and detected by RCA using only anti-digoxigenin
antibodies and the corresponding decorators, and serum
samples labeled with digoxigenin were incubated and
detected by RCA using only anti-biotin antibodies and the
corresponding decorators. Among the 56 capture antibodies
tested, none exhibited reactivity with the anti-biotin or anti-
digoxigenin antibodies when using the hydrogel substrate,
and five antibodies showed some reactivity with the anti-dig-
oxigenin when using the nitrocellulose substrate (data not
shown). Those antibodies were excluded from subsequent
experiments.
Demonstration of two-color signal amplification
The signal amplification from the use of RCA was evaluated
by comparison with direct labeling and indirect detection of
multiple proteins from two different serum samples. Each
serum sample was measured against itself as the reference
using antibody microarrays prepared on both hydrogels and
nitrocellulose. Experiments were performed in duplicate.
Representative images (Figure 2) from the 24 arrays showed
the relative signal strengths and background levels. The fluo-
rescence signals from microarrays detected with RCA were
significantly higher than those detected with either direct
labeling or indirect detection, and some antibody spots seem
to be visible only with RCA detection. The background-sub-
tracted fluorescence (averaged over the four experiments forhttp://genomebiology.com/2004/5/4/R28 Genome Biology 2004,     Volume 5, Issue 4, Article R28       Zhou et al. R28.3
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each condition) of each antibody was plotted for each condi-
tion (Figure 3a,b,c,d). In each color channel, and on each sub-
strate, the signal intensities from RCA are significantly higher
than those from the other two methods. Per antibody, the
i n c r e a s e  r a n g e d  f r o m  t w o f o l d  u p  t o  3 0 - f o l d  o n  b o t h  s u b -
strates. Several antibodies produced measurable signal (that
is, surpassing the threshold defined in the Materials and
methods section) only using RCA.
The variation between the detection methods in background
intensity was different for the two substrates (Figure 3e,f). On
the hydrogel substrate, the background intensity did not
change between detection methods (Figure 3e). On the nitro-
cellulose substrate, the background was lowest using indirect
detection and was similar between direct detection and RCA
(Figure 3f). Thus the variation in signal relative to back-
ground was also different between the substrates. On the
hydrogels, RCA produced the highest signal relative to back-
ground, with the other detection methods similar to each
other. On the nitrocellulose, indirect detection and RCA had
similar signal levels relative to background, as RCA had
higher signals but also proportionately higher backgrounds
than indirect detection. Direct labeling on nitrocellulose had
the lowest signals relative to background, and that method
was not tested further.
Validation using clinical samples
Having established that two-color RCA provided significant
signal amplification in both color channels, it was important
to evaluate the method's reproducibility, accuracy and
sensitivity in applications using clinical samples. The per-
formance of two-color RCA, indirect detection and direct
Schematic representation of two-color RCA on antibody microarrays Figure 1
Schematic representation of two-color RCA on antibody microarrays. 
Two pools of proteins are respectively labeled with digoxigenin (C1, 
digoxigenin-labeled protein, digoxigenin represented by the triangle) and 
biotin (C2, biotin-labeled protein, biotin represented by the diamond). 
Primer 4.2-conjugated anti-digoxigenin (B1) and primer 1-conjugated anti-
biotin (B2) bind to captured proteins, followed by hybridization of circle 
4.2 (A1) and circle 1 (A2). Polymerase extends the primers using the 
circles as templates. Cy5-labeled oligonucleotides (D1), complementary to 
the extended DNA from primer 4.2, and Cy3-labeled oligonucleotides 
(D2), complementary to the extended DNA from primer 1, are hybridized 
to the extended DNA strands, producing signal amplification in two 
colors.
A1
B1
C1
D1
A2
B2
C2
D2
Representative images of antibody microarrays Figure 2
Representative images of antibody microarrays. A serum sample was 
incubated on antibody microarrays prepared on hydrogels (left) and 
nitrocellulose (right) and detected with direct labeling (top), indirect 
detection (middle), and RCA (bottom). The same serum sample was used 
in each color channel for each experiment. Scanner settings were identical 
within microarrays performed on the same substrate.
Hydrogel Nitrocellulose
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Figure 3 (see legend on next page)
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labeling were compared in a series of experiments profiling
proteins in a set of 24 serum samples; each experiment was
performed in duplicate using antibody microarrays prepared
on nitrocellulose. The nitrocellulose substrate was chosen
because of more consistent print quality and overall better
signal strengths compared to the hydrogel surface. The levels
of the proteins von Willebrand factor, IgG, and IgA were also
measured in each sample by ELISA.
The reproducibility of the antibody-microarray measure-
ments was evaluated by calculating the Pearson correlation
between measurements from duplicate sets of 24 microar-
rays. A visual representation of the reproducibility is pro-
vided by a cluster (Figure 4) in which replicate sets of
microarray measurements from each antibody were placed in
adjacent rows, with the correlation between the duplicate sets
indicated to the right of the antibody names. Each of the 24
columns represents data from a serum sample over the repli-
cate experiment sets, and the columns were clustered by sim-
ilarity in expression of all the proteins. The pattern of
measurements across the 24 samples is highly consistent
between replicate experiments within each antibody, both for
the duplicate RCA sets and the duplicate indirect-detection
sets. The duplicate RCA sets had correlations similar to those
from indirect detection. For example, both the RCA duplicate
measurements and the indirect-detection duplicate measure-
ments of anti-urokinase-like plasminogen activator (anti-
uPA) had correlations of 0.95. Other antibodies showed more
variation between the detection methods, but in general no
clear advantage in reproducibility was observed for either
method.
The cluster also showed that the RCA measurements agreed
very well with both the indirect-detection measurements and
with the ELISA measurements. The correlations between the
average RCA measurements and the average indirect-detec-
tion measurements (indicated by the outer numbers on the
right of Figure 4) are similar to the correlations within each
detection method, sometimes slightly less. Most correlations
between the detections methods are 0.7-0.8, and several are
above 0.9. The independently collected ELISA measurements
of three of the proteins are also included in the cluster. Both
the RCA measurements and the indirect-detection measure-
ments substantially agree with the ELISA values, with corre-
lations in the 0.8-0.9 range.
The expression patterns of the antibodies were distinct from
each other, consistent with the binding of distinct, specific
components of the serum. The samples from patients with
liver cancer or cirrhosis showed generally higher levels of
most proteins as compared to the samples from healthy con-
trols, although the samples from similar disorders do not co-
cluster, indicating that the pattern of measurements from
these proteins is not specific for a particular disease state.
Some antibodies in the cluster have only RCA measurements
included in the cluster, such as one of the anti-IL-6 antibod-
ies, anti-IGFBP-3, and anti-TSP-1. These antibodies pro-
duced measurements for fewer than half of the samples using
indirect detection, and those measurements were not
included.
The relative detection sensitivity of RCA and the other detec-
t i o n  m e t h o d s  i s  i n  p a r t  i n d i cated by the range of protein
measurements enabled by each method, and a more sensitive
method should enable measurements of a greater number of
proteins in a greater number of samples. In three sets of
experiments comparing RCA to either direct labeling or indi-
rect detection, the number of serum samples out of a set of 24
(averaged over duplicate experiment sets) in which protein
binding was measurable (that is, surpassing the threshold
defined in the Materials and methods section) was summed
for each antibody (Figure 5). In the first set (Figure 5a), serum
proteins from liver cancer, cirrhotic and pre-cirrhotic
patients and controls were measured by both RCA and direct-
labeling detection using antibody microarrays printed on the
hydrogel substrate. The second set (Figure 5b) was identical
to the first but compared RCA to indirect detection instead of
direct-labeling detection. And the third set (Figure 5c) was
identical to the second but used microarrays printed on nitro-
cellulose instead of hydrogels.
In each comparison, RCA detection resulted in an increased
number of measurements for several different antibodies (see
Table 1 for antibody identities). Antibodies targeting higher-
abundance proteins (for example, AB07 (anti-IGG1), AB14
(anti-alkaline phosphatase), AB33 (anti-hemoglobin), AB34
(anti-IgA), and AB35 (anti-transferrin)) produced measure-
ments in all the samples in each condition and detection
method. Antibodies that always produced more measure-
ments when using RCA generally targeted lower-abundance
proteins (for example, AB03 (anti-urokinase-like plasmino-
gen activator), AB05 (anti-lactate dehydrogenase 1, 2, 3 and
4), AB12 (anti-IL-6), and AB22 (anti-IL-6)). The measure-
ments gained by RCA also were highly reproducible. In the
data from Figure 5c and Figure 4, the antibodies AB03, AB05,
AB12, and AB22, which each resulted in significantly more
Net signal intensities and backgrounds Figure 3 (see previous page)
Net signal intensities and backgrounds. Serum samples were incubated on antibody microarrays prepared on hydrogels and nitrocellulose and detected 
with direct labeling, indirect detection, and RCA. Two different serum samples were measured in duplicate for each condition, using the same serum 
sample in both color channels (635 and 532). The net signal is the background-subtracted, median intensity of each antibody spot, averaged over the four 
replicate experiments. Scanner settings were identical within microarrays performed on the same substrate. (a-d) The distribution of average background-
subtracted intensities of the antibody spots for the indicated substrates, color channels and detection methods. (e, f) The average background levels for 
each detection method and substrate.R28.6 Genome Biology 2004,     Volume 5, Issue 4, Article R28       Zhou et al. http://genomebiology.com/2004/5/4/R28
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Figure 4 (see legend on next page)
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measurements with RCA, produced inter-set correlations of
0.95, 0.95, 0.7, and 0.93, respectively. A full comparison of
the inter-set correlations is presented in Table 1. Compari-
sons of data from some antibodies were not possible in cer-
tain sets if not all arrays within a batch were printed
consistently, as noted in Table 1. Difficulties in consistent
printing were especially experienced when using a contact
printer on the hydrogel substrate.
Discussion
This work was motivated by our earlier experience with the
use of antibody arrays to detect fluorophore-labeled proteins
in serum samples [7]. We found that while direct fluorophore
labeling performed well in the detection of higher-abundance
proteins, the sensitivity was not sufficient to allow measure-
ments of many potentially useful and interesting mid- to low-
abundance proteins. We recognized the fundamental
advantages of label-based detection, namely the ease of assay
development for new targets and the requirement for only
one antibody per target, as compared to two for sandwich
assays. Therefore, we sought methods to improve the sensi-
tivity of detection of labeled proteins. RCA was a good method
to test for this purpose. RCA, in contrast to certain enzymatic
or chemiluminescent amplification methods, could be readily
adapted to produce signal amplification in two color chan-
nels, which was important to allow the co-incubation of a ref-
erence sample on the arrays. Also, the extended DNA strand
produced by RCA is covalently attached to the detecting anti-
body, so the amplified fluorescent signal cannot diffuse away.
This feature is critical in a planar format with distinct assays
in neighboring spots.
We first established that RCA was in fact providing significant
fluorescence enhancement in two colors. The net fluores-
cence intensities from RCA were significantly greater, up to
30-fold, than those from direct labeling or indirect detection
on both substrates, and some antibodies produced measura-
ble signal only when using RCA. This signal increase is less
than the up to 1,000-fold increase reported previously [14] in
amplifications of tethered primers. This lower level of
observed amplification could be because we were amplifying
from an antibody-antigen-detection antibody complex, which
might partly dissociate in the increased steps and washes
used in RCA as compared to non-RCA, or because the
complex might not be as amenable to amplification as the
tethered primer. Also, we were comparing to multiply labeled
proteins and antibodies, which would reduce the relative
increase observed with RCA. Other publications describing
the use of RCA for immunoassays did not report a quantita-
tive comparison of amplified versus nonamplified fluores-
cence, but one reported an approximate two orders of
magnitude reduction in detection limits compared to conven-
tional ELISAs [17]. The background level varied between
detection methods when using the nitrocellulose substrate,
but not when using the hydrogels. The hydrogel substrate is
apparently so resistant to nonspecific protein binding that the
background is at a minimum and is unaffected by changes in
label concentrations in the samples. The nitrocellulose more
readily binds proteins nonspecifically, as was reflected in the
difference between the detection methods in background lev-
els. Indirect detection had the lowest background levels on
nitrocellulose as the fluorophore concentration was lowest.
As the net signal levels from indirect detection were similar to
those from direct labeling, indirect detection was better than
direct labeling on the nitrocellulose. RCA, by comparison to
indirect detection, amplified both the background and sig-
nals. Although the background was amplified also, the higher
net signal from RCA still improved the detection of low-abun-
dance proteins.
With any amplification method it is important to confirm
reproducibility, accuracy, and lack of introduction of system-
atic bias. The amplification process in general did not have a
negative effect on reproducibility, as the correlations between
replicate RCA measurements and between replicate indirect
detection measurements were very similar. The fact that RCA
and indirect detection measurements correlated with each
other also indicated that the amplification process did not
introduce systematic error. The agreement of both types of
measurements with ELISA measurements indicated that, at
least for those proteins tested, the results were accurate. The
accuracy of the microarray measurements may also be
inferred from the distinct expression profiles obtained from
each antibody, which are consistent with the binding of spe-
cific and distinct components of the serum samples. In
addition, the rise in abundance of several different proteins in
association with disease is consistent with many previous
observations, further supporting the accuracy of the
measurements.
We assessed whether the amplified signal demonstrated in
Figures 2 and 3 translated into the ability to detect a greater
number of proteins in a greater number of samples. The
Cluster of RCA and indirect-detection measurements Figure 4 (see previous page)
Cluster of RCA and indirect-detection measurements. Twenty-four serum samples were incubated in duplicate on unique antibody microarrays prepared 
on nitrocellulose and detected with either RCA or indirect detection. Replicate experiment sets from each antibody are grouped in adjacent rows, and the 
correlations between adjacent rows are indicated to the right of the labels. The 24 columns, representing the data from each serum sample over the 
replicate experiment sets, were clustered by similarity in expression of all the proteins. The color of the column label indicates the clinical category of the 
patient from which the serum sample was taken: red, liver cancer; brown, cirrhosis; blue, pre-cirrhosis; green, healthy. Independently collected ELISA data 
are included for the proteins von Willebrand factor, IgA, and IgG (labels highlighted). The data were median centered in the row dimension, and the color 
and intensity of each square indicates the expression relative to other data in the row: red, high; green, low; black, medium; gray, missing data.R28.8 Genome Biology 2004,     Volume 5, Issue 4, Article R28       Zhou et al. http://genomebiology.com/2004/5/4/R28
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percentage of samples in which proteins are measurable is a
good indicator of a detection method's sensitivity relative to
the concentration range of a protein. In three separate
c o m p a r i s o n s  o f  R C A  t o  e i t h e r  direct-labeling or indirect-
detection methods and on either hydrogel or nitrocellulose
substrates, the use of RCA yielded measurements from an
Number of samples yielding measurable data for each antibody Figure 5
Number of samples yielding measurable data for each antibody. RCA (gray bars) was compared to either direct labeling or indirect detection (dark bars) in 
the measurement of 24 serum samples in duplicate. For each antibody, the number of samples producing measurements above the detection threshold (as 
defined in Materials and methods) was summed and averaged over the duplicate experiment sets (see Table 1 for antibody IDs and summary of 
correlations between replicate experiment sets). (a) RCA compared to direct labeling on hydrogels using samples from liver cancer patients and controls. 
(b) RCA compared to indirect detection on hydrogels using samples from liver cancer patients and controls. (c) RCA compared to indirect detection on 
nitrocellulose using samples from liver cancer patients and controls.
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increased number of samples for multiple antibodies. The
new measurements afforded by RCA were highly reproduci-
ble and had distinct expression patterns, as shown in the clus-
ter of Figure 4. Also, the measurements gained were of lower-
abundance proteins normally outside the detection limit of
the direct-labeling method. The repeated demonstration
under a variety of conditions of an increased number of dis-
tinct and reproducible measurements of lower-abundance
proteins is strong evidence that two-color RCA does in fact
improve the detection sensitivity of the antibody microarray
assay.
The actual quantified detection limits vary according to the
antibody used and are difficult to measure without known
standards to construct calibration curves. The detection lim-
its can be estimated on the basis of the known concentration
ranges of the target antigens. For example, IL-6, which was
measurable to a greater extent by RCA as compared to
Table 1
Antibodies used in Figure 5 and 5a summary of inter-set correlations
Antibody name RCA/direct (Figure 5a) RCA/indirect (Figure 5b) RCA/indirect (Figure 5c)
AB01 VAI00101 anti-cathepsin B (ab-1) -/- 0.99/- 0.83*/-
AB02 VAI00194 anti-von Willebrand factor 0.94/0.99 0.94/0.8 0.79/0.6
AB03 VAI00198 anti-uPA -/- -/- 0.95/0.95
AB05 VAI00233 anti-LD1234 0.8/- 0.8/- 0.95/-
AB06 VAI00243 anti-IL-1alpha 0.99/- 0.99/- 0.97/0.98
AB07 VAI00244 anti-IGG1 0.94/0.95 0.94/0.67 0.87/0.74
AB08 VAI00245 anti-complement C3 0.82*/0.97 0.82*/- 0.99/0.68*
AB09 VAI00246 anti-complement C4 0.93/0.98 0.93/0.79 0.78/0.81
AB10 VAI00261 anti-VEGF 0.84*/0.95 0.84*/- 0.77/0.69
AB11 VAI00263 anti-alpha2-macroglobulin 0.71/0.99 0.71/0.77 0.67/0.91
AB12 VAI00269 anti-IL-6 0.74*/- 0.74*/- 0.7/-
AB13 VAI00273 anti-ceruloplasmin -/0.71 -/- 0.98/0.87
AB14 VAI00274 anti-AP 0.98/0.93 0.98/0.74 0.9/0.77
AB15 VAI00276 anti-Alpha-1-AT 0.95/0.95 0.95/- 0.75/0.86
AB16 VAI00277.1 anti-haptoglobulin 0.96/- 0.96/- 0.95/0.89
AB17 VAI00282 anti-alpha-fetoprotein 0.98/0.98 0.98/0.98 0.89/0.9
AB18 VAI00297 anti-Timp-1 -/- -/- 0.96/0.96
AB19 VAI00298 anti-IGFBP-3 0.99/0.97 0.99/0.69 0.86/0.26*
AB20 VAI00300 anti-IL-8 0.99/0.96 0.99/0.77 0.92/0.97
AB21 VAI00303 anti-VEGF 0.63*/0.83 0.63*/0.77* 0.66/0.87
AB22 VAI00305 anti-IL-6 -/- -/- 0.93/0.95
AB23 VAI00307 anti-IL-2 0.78/0.96 0.78/- 0.87/0.63
AB24 VAI00308 anti-TSP-1 0.91/0.95 0.91/- 0.9/-
AB25 VAI00338 anti-plasminogen 0.96/- 0.96/- 0.88/0.89
AB26 VAI00339 anti-CA125 0.92*/- 0.92*/- 0.94/0.76
AB27 VAI00342 anti-CEA 0.93/0.91 0.93/0.73 0.84/0.71
AB28 VAI00348 anti-beta2-microglobulin 0.98/- 0.98/- 0.88/0.91
AB29 VAI00352 anti-PAI 0.77/0.87 0.77/- 0.95/0.87
AB30 VAI01032 anti-alpha1 ACT 0.96/0.92 0.96/0.95 0.91/0.95
AB31 VAI01126 anti-albumin 0.88/0.94 0.88/0.72 0.82/0.56*
AB32 VAI10003 anti-IgG-Fc 0.98/0.98 0.98/0.95 0.87/0.95
AB33 VAI10007 anti-hemoglobin 0.97/0.99 0.97/1 0.87/0.8
AB34 VAI10011 anti-IgA 0.92/0.99 0.92/0.86 0.88/0.97
AB35 VAI10013 anti-transferrin 0.82/0.96 0.82/0.75 0.63/0.79
For each antibody, the correlation between replicate sets of 24 microarrays is given, both for RCA and for direct labeling or indirect detection. The 
correlation is the Pearson correlation in the overlap between the sets, that is, using only samples for which measurements were available in both 
sets. Correlations were not calculated if the overlap between the duplicate sample sets was less than three samples or less than half the samples from 
one of the sets. Asterisk, not a statistically significant correlation, using a 99% confidence level based on the size of overlap between sets.R28.10 Genome Biology 2004,     Volume 5, Issue 4, Article R28       Zhou et al. http://genomebiology.com/2004/5/4/R28
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indirect detection or direct labeling, is typically present in the
serum at concentrations of 0.001-100 ng/ml, which gives
some indication that two-color RCA may be able to detect
antigens in the low-to-mid pg/ml range. Previous use of RCA
in chip-based sandwich immunoassays reported detection
limits below 1 pg/ml [14], showing that sandwich immu-
noassays have the potential for very low detection limits. We
have not carried out a direct comparison of detection limits
between two-color RCA and sandwich one-color RCA.
Here we present early investigations, and further optimiza-
tion could further reduce detection limits and improve the
applicability of the method. It will be interesting to test alter-
native protein-labeling strategies, such as the use of cisplatin
derivatives to label cysteine, methionine, and histidine
groups [18], as the labeling of certain proteins through the
surface amine groups may interfere with antibody binding.
The alternative labeling strategy may provide better detection
of certain proteins and worse detection of others. Another
task for optimizing the application of this technology will be
to define the linear response range for the various protein tar-
gets. The reduction of detection limits by RCA shifts the linear
response range of the assay to lower concentrations, and var-
ious proteins will be measured optimally at different serum
dilutions. We are now in the process of determining the effect
of protein concentration and serum dilution on the measure-
ment characteristics of each antibody.
We now have a convenient method for probing a wide range
of proteins in a flexible and rapidly customizable assay. This
method represents a valuable complement to the sandwich
format. While the potential for fine specificity is sacrificed
when using one antibody instead of two, a great diversity of
antibodies and novel targets may be probed rapidly, perhaps
enabling the acquisition of broader, as opposed to more spe-
cific, information. As new potential protein markers are iden-
tified through RNA expression profiling and other methods, it
will be important to expeditiously test each protein both alone
and in combination with other potential markers. In addition,
the increasing knowledge of the protein composition of serum
and plasma [19] compels exploration of the variation of these
proteins in the population and as a function of disease. The
ability to undertake such explorations, potentially enabled by
the method presented here, should be valuable for basic and
applied research applications.
Materials and methods
Serum samples
A set of 24 serum samples, collected at the University of Mich-
igan Hospital, consisted of samples from six liver cancer
patients, six pre-cirrhotic patients, six cirrhotic patients, and
six normal controls. All samples were stored frozen at -80°C
and had been thawed no more than three times before use. All
samples were collected under protocols approved by local
Institutional Review Boards for human subjects research.
Fabrication of antibody microarrays
Antibodies were purchased from various sources. A list sum-
marizing the sources, catalog numbers, and other informa-
tion about the antibodies is provided in the supplementary
information at reference [20]. Antibodies that were supplied
in ascites fluid or antisera were purified using Protein A beads
(Affi-gel Protein A MAPS kit, Bio-Rad) according to the man-
ufacturer's protocol. Samples (10-15 µl each) of 100-2000 µg/
ml antibody solutions in 1x PBS were prepared in polypropyl-
ene 384-well microtiter plates (Genetix). Two types of
machines, a custom-built robotic microarrayer and a piezo-
electric non-contact spotter (Biochip Arrayer, PerkinElmer
Life Sciences), transferred small amounts of each antibody
solution to the surfaces of coated microscope slides. Antibod-
ies were deposited six to eight times each onto slides coated
with either a polyacrylamide hydrogel (HydroGel, Perk-
inElmer Life Sciences) or nitrocellulose (FAST slides, Sch-
leicher & Schuell). Before printing, the hydrogel-coated slides
were treated as described [7]. The slides were washed for 10
min each in three changes of purified water, dried by centrif-
ugation, and incubated at 40°C for 20 min. The nitrocellu-
lose-coated slides needed no pretreatment before printing.
Each printed microarray was circumscribed using a hydro-
phobic marker PAP pen, leaving about 3 mm between the
array boundary and the hydrophobic border.
The nitrocellulose-coated slides were blocked overnight at
4°C in 1x Tris-buffered saline (TBS) with 1% BSA and 0.1%
Tween-20 (TBST0.1), then briefly rinsed with 1x PBS/0.5%
Tween-20 (PBST0.5) before use. The hydrogel-coated slides
were incubated overnight at room temperature in a humidi-
fied chamber to allow the antibodies to bind to the hydrogel
matrix. They were washed for 30 sec, 3 min and 30 min in 1x
PBS with 0.5% Tween-20 (PBST0.5), blocked for 1 h at room
temperature in 1% BSA/PBST0.5, and washed briefly two
times in PBST0.5 before use.
Serum labeling
For one group of experiments, an aliquot from each of 24
serum samples was labeled with Cy3 (Amersham), and
another aliquot was labeled with Cy5 (Amersham). Each
serum aliquot was diluted 1:15 with 50 mM carbonate buffer
at pH 8.3, and 1/20 volume of 6.7 mM N-hydroxysuccinimide
(NHS) ester-linked Cy3 or Cy5 (Amersham) in DMSO was
added. After the reactions had proceeded for 2 h on ice, 1/20
volume of 1 M Tris-HCl (pH 8.0) was added to each tube to
quench the reactions and the solutions were allowed to sit for
another 20 min. The unreacted dye was removed by passing
each solution through a size-exclusion chromatography spin
column (Bio-Spin P6, Bio-Rad) with a molecular weight cut-
off of 6,000 Da. The Cy5-labeled samples were pooled, and
equal amounts of the pool were transferred to each of the Cy3-
labeled samples. Each dye-labeled protein solution was
supplemented with non-fat milk to a final concentration of
3%, Tween-20 to a final concentration of 0.1%, and 1x PBS to
yield a final serum dilution of 1:100.http://genomebiology.com/2004/5/4/R28 Genome Biology 2004,     Volume 5, Issue 4, Article R28       Zhou et al. R28.11
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For the other experiment sets, one aliquot from each of 24
serum samples was labeled with NHS-digoxigenin (Molecular
Probes), and another aliquot was labeled with NHS-biotin
(Molecular Probes). The labeling procedure was identical to
that described above. The digoxigenin-labeled samples were
pooled and distributed among the biotin-labeled samples
prior to the addition of non-fat milk, Tween-20 and PBS in
the same proportions as above.
Processing of antibody microarrays
A 100 µl sample of each labeled serum sample mix was incu-
bated on a microarray with gentle rocking at room tempera-
ture for 2 h. The microarrays were rinsed briefly in PBST0.1
to remove the sample, washed three times for 10 min each in
PBST0.1, and dried by centrifugation. Microarrays that had
been incubated with Cy3/Cy5-labeled samples were ready for
scanning. Microarrays that had been incubated with biotin/
digoxigenin-labeled samples were processed for either indi-
rect detection or RCA detection.
For indirect detection, the microarrays were incubated under
gentle rocking for 1 h at room temperature with Cy3-labeled
anti-biotin and Cy5-labeled anti-digoxigenin antibodies, each
prepared at 0.5 µg/ml in 1x PBST0.1 with 1% BSA. The anti-
bodies were labeled according to the labeling protocol above.
After three room-temperature washes under rocking for 10
min each in PBST0.1, the microarrays were ready for scan-
ning. The following reagents specific for RCA detection were
kindly provided by Molecular Staging (New Haven, CT): anti-
biotin antibody covalently conjugated to a 20-base oligonu-
cleotide (primer 1); anti-digoxigenin antibody covalently con-
jugated to a different 20-base oligonucleotide (primer 4.2);
81-base circular DNA (circle 1) with a portion complementary
to primer 1; and 80-base circular DNA (circle 4.2) with a por-
tion complementary to primer 4.2 (the sequences of the prim-
ers, circles and decorators can be found in the supplementary
information at ref [20]). The microarrays were incubated for
1 h at room temperature with a solution containing 75 nM cir-
cle 1, 75 nM circle 4.2, 1.0 µg/ml primer 1-conjugated anti-
biotin, and 1.0 µg/ml primer 4.2-conjugated anti-digoxigenin
in PBST0.1 with 1 mM EDTA and 5 mg/ml BSA. The microar-
rays were rinsed briefly in PBST0.1 and washed at room tem-
perature with gentle rocking three times for 10 min each in
PBST0.1. Phi29 DNA polymerase (TempliPhi, Amersham) in
1x Tango buffer (Fermentas, Hanover, MD) solution with
0.1% Tween-20 and 1 mM dNTPs was incubated on the arrays
at 37°C for 30 min. The microarrays were rinsed briefly in 2x
SSC/0.1% Tween-20, washed three times for 10 min each at
room temperature with gentle rocking in 2x SSC/0.1%
Tween-20, and dried by centrifugation. A Cy3-labeled 18-bp
oligonucleotide (decorator 1) complementary to the repeating
DNA strand from primer 1 and a Cy5-labeled 22-bp oligonu-
cleotide (decorator 4.2) complementary to the repeating DNA
strand from primer 4.2 were prepared at 0.2 mM each in 2x
SSC with 0.1% Tween-20 and 0.5 mg/ml herring sperm DNA.
This solution was incubated on the microarrays for 1 h at 37°C
with gentle rocking. The microarrays were briefly rinsed in 2x
SSC/0.1% Tween-20, washed three times for 10 min each at
room temperature in 2x SSC/0.1% Tween-20, and dried by
centrifugation.
ELISA measurements were made according to protocols sup-
plied with kits for IgM, IgG, IgA, and von Willebrand factor
(Bethyl, Montgomery, TX).
Analysis
The microarrays were scanned (ScanArray, PerkinElmer Life
Sciences) for fluorescence using laser excitation at 532 and
635 nm, and the program GenePix 4.0 (Axon Instruments)
was used to quantify the images. An intensity threshold for
each antibody spot was calculated by the formula 3 × B × CVb,
where B is each spot's median local background and CVb is the
average coefficient of variation (standard deviation divided
by the average) of all the local backgrounds on the array. (This
threshold is similar to the standard deviation of the local
background but minimizes the effects from spikes in the local
backgrounds.) For spots with fluorescence signal surpassing
the threshold in both color channels, the ratio of background-
subtracted median sample-specific fluorescence to back-
ground-subtracted median reference-specific channel fluo-
rescence was calculated, and ratios from replicate antibody
measurements within the same array were averaged. The
resulting ratios were multiplied by a normalization factor for
each array, N, that was calculated by N = (SIgM / µIgM) / RIgM,
where RIgM is the average ratio of the replicate anti-IgM anti-
body spots on a particular array, SIgM is the ELISA-measured
IgM concentration of the serum sample on that array, and
µIgM is the mean ELISA-measured IgM concentration of all of
the samples [7].
Hierarchical clustering and visualization were performed
using Cluster and Treeview [21] (see [22]). Ratios were log-
transformed (base 2) and median centered (by genes), and
antibodies that did not have measurements in at least 50% of
the samples were removed.
Additional data files
The following additional data files are provided with the com-
plete version of this article, online: The net signals and back-
grounds from the experiments on hydrogel slides used in
figures 2 and 3 (Additional data file 1); the net signals and
backgrounds from the experiments on nitrocellulose slides
used in figures 2 and 3 (Additional data file 2); the averaged
and normalized data used in figures 4 and 5C from set one of
the indirect detection experiments (Additional data file 3);
the averaged and normalized data used in figures 4 and 5C
from set two of the indirect detection experiment (Additional
data file 4); the raw ratios (not averaged or normalized) used
in figures 4 and 5C from set one of the indirect detection
experiments (Additional data file 5); the raw ratios (not aver-
aged or normalized) used in figures 4 and 5C from set two ofR28.12 Genome Biology 2004,     Volume 5, Issue 4, Article R28       Zhou et al. http://genomebiology.com/2004/5/4/R28
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the indirect detection experiments (Additional data file 6);
the averaged and normalized data used in figures 4 and 5C
from set one of the RCA detection experiments (Additional
data file 7); the averaged and normalized data used in figures
4 and 5C from set two of the RCA detection experiments
(Additional data file 8); the raw ratios (not averaged or nor-
malized) used in figures 4 and 5C from set one of the RCA
detection experiments (Additional data file 9); the raw ratios
(not averaged or normalized) used in figures 4 and 5C from
set two of the RCA detection experiments (Additional data file
10); the Elisa values that were used for normalization of the
data (Additional data file 11); the antibodies used in this study
(Additional data file 12); and, finally, the sequences for the
primers, circles and decorators used in this study (Additional
data file 13). The files are also available at [20].
Additional data file 1 The net signals and backgrounds from the experiments on hydrogel  slides used in figures 2 and 3 The net signals and backgrounds from the experiments on hydrogel  slides used in figures 2 and 3 Click here for additional data file Additional data file 2 The net signals and backgrounds from the experiments on nitrocel- lulose slides used in figures 2 and 3 The net signals and backgrounds from the experiments on nitrocel- lulose slides used in figures 2 and 3 Click here for additional data file Additional data file 3 The averaged and normalized data used in figures 4 and 5C from set  one of the indirect detection experiments The averaged and normalized data used in figures 4 and 5C from set  one of the indirect detection experiments Click here for additional data file Additional data file 4 The averaged and normalized data used in figures 4 and 5C from set  two of the indirect detection experiment The averaged and normalized data used in figures 4 and 5C from set  two of the indirect detection experiment Click here for additional data file Additional data file 5 The raw ratios (not averaged or normalized) used in figures 4 and  5C from set one of the indirect detection experiments The raw ratios (not averaged or normalized) used in figures 4 and  5C from set one of the indirect detection experiments Click here for additional data file Additional data file 6 The raw ratios (not averaged or normalized) used in figures 4 and  5C from set two of the indirect detection experiments The raw ratios (not averaged or normalized) used in figures 4 and  5C from set two of the indirect detection experiments Click here for additional data file Additional data file 7 The averaged and normalized data used in figures 4 and 5C from set  one of the RCA detection experiments The averaged and normalized data used in figures 4 and 5C from set  one of the RCA detection experiments Click here for additional data file Additional data file 8 the averaged and normalized data used in figures 4 and 5C from set  two of the RCA detection experiments the averaged and normalized data used in figures 4 and 5C from set  two of the RCA detection experiments Click here for additional data file Additional data file 9 The raw ratios (not averaged or normalized) used in figures 4 and  5C from set one of the RCA detection experiments The raw ratios (not averaged or normalized) used in figures 4 and  5C from set one of the RCA detection experiments Click here for additional data file Additional data file 10 The raw ratios (not averaged or normalized) used in figures 4 and  5C from set two of the RCA detection experiments The raw ratios (not averaged or normalized) used in figures 4 and  5C from set two of the RCA detection experiments Click here for additional data file Additional data file 11 The Elisa values that were used for normalization of the data (Addi- tional data file The Elisa values that were used for normalization of the data (Addi- tional data file Click here for additional data file Additional data file 12 The antibodies used in this study The antibodies used in this study Click here for additional data file Additional data file 13 The sequences for the primers, circles and decorators used in this  study The sequences for the primers, circles and decorators used in this  study Click here for additional data file
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